Director, Division of Human Tissues
FDA/CBER/Office of Tissues and Advanced Therapies
Silver Spring, MD, United States
Scott Brubaker was selected in October 2016 as the Director, Division of Human Tissues (DHT) in the Office of Tissues & Advanced Therapies (OTAT) within the Center for Biologics Evaluation & Research (CBER) at the Food & Drug Administration (FDA). Prior to that he served 12 years as Senior Vice President of Policy at the American Association of Tissue Banks (AATB) where duties included oversight of the Accreditation Program and the development and management of the Association’s policies, professional standards and guidance documents. Before joining AATB, Scott acquired 18 years of practical experience involving organ donation and tissue banking while holding various management positions at an OPO/Tissue Bank in Virginia. Scott is co-editor of three “Essential Guide” books covering cell and tissue donation, processing, and clinical use, and has authored or co-authored more than 40 scientific publications.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thursday, October 20, 2022
8:00 AM – 9:00 AM US ET
Thursday, October 20, 2022
8:40 AM – 9:00 AM US ET